Valpodax CR 200

Valpodax CR-200 combines Sodium Valproate (134 mg) and Valproic Acid (58 mg) in a controlled-release formulation designed for the effective management of epilepsy and bipolar disorder. This combination works to stabilize mood and prevent seizures by increasing the levels of gamma-aminobutyric acid (GABA) in the brain which has calming effects on neural activity. The controlled-release feature ensures consistent medication delivery enhancing therapeutic effectiveness and patient compliance.